missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ SARS-CoV-2 Nucleocapsid/Spike Protein (RBD) Recombinant Protein
Description
Animal Origin Free Purity is >95% by SDS-PAGE.
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold symptoms to severe effects including death and respiratory distress. The CoV Spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines. Of note is the Spike protein receptor-binding domain (RBD, S-RBD) in SARS-CoV-2 Spike protein which binds strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. SARS-CoV-2 RBD exhibits significantly higher binding affinity to ACE2 receptor than SARS-CoV RBD in comparison. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells.
Specifications
Specifications
| Concentration | 1.5 mg/mL |
| For Use With (Application) | Control, ELISA Standard, Binding Assay |
| Formulation | PBS with no preservative; pH 7.4 |
| Name | SARS-CoV-2 Nucleocapsid/Spike Protein (RBD) |
| pH Range | 7.4 |
| Purification Method | Purified |
| Quantity | 100 μg |
| Source | E. coli |
| Storage Requirements | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| Regulatory Status | RUO |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?